Muscular dystrophies are diseases characterized by muscle weakness together with cycles of degeneration and regeneration of muscle fibers, resulting in a progressive decrease of muscle mass, diminished muscle force generation and an increase in fibrosis. Fibrotic disorders are the endpoint of many chronic diseases in different tissues, where accumulation of the extracellular matrix (ECM) occurs. Connective tissue growth factor CTGF/CCN2, which is overexpressed in muscular dystrophies, correlates with the degree and severity of fibrosis in many diseases. However, the role of CTGF/CCN2 in skeletal muscle fibrosis characteristic of Duchenne Muscular Dystrophy (DMD) remains unknown. To test the hypothesis that CTGF might not only contribute to conversion of already damaged muscle into scar tissue, but that it could by itself also directly contribute to skeletal muscle deterioration, we used two experimental approaches: 1) Determine the effect of loss of CTGF function in the progression of fibrosis in mdx mice, a murine model of DMD, in a genetically CTGF-reduced model (mdx-CTGF +/− mice) and a decrease of CTGF activity model (blocking antibodies). 2) Evaluate the effect of gain of CTGF levels through overexpression in the tibialis anterior muscle of wild-type mice using an adenovirus containing the CTGF mouse sequence (Ad-mCTGF). CTGF protein levels were significantly elevated in the muscles of dystrophic mdx mice compared to wild-type mice. CTGF levels were significantly reduced in mdx-CTGF +/− mice and this correlated with a significant decrease of fibrosis, as determined by fibronectin and collagen levels. We also detected less muscle damage in mdx-CTGF +/− mice compared to mdx mice, as evidenced by more normal muscle tissue structure and reduced levels of myogenic precursors such as myogenin and embryonic myosin. Impressively, the decrease of CTGF in mdx-CTGF +/− mice caused an improvement of the specific isometric contractile force despite the absence of dystrophin.
FG-3019 is an antibody inhibitor of CTGF that is currently in clinical trials for treatment of pulmonary and liver fibrosis and pancreatic cancer. Administration of FG-3019 to mdx mice for 1 month produced a similar effect as genetic depletion, resulting in decreased fibrosis and increased isometric contractile force.
In contrast, CTGF overexpression induced extensive skeletal muscle damage, which was followed by a massive regeneration of the damaged muscle, as indicated by increased embryonic myosin and fibers with centrally located nuclei. It also induced strong fibrosis with increased levels of fibronectin, collagen, decorin and α-smooth muscle actin (α-SMA). Moreover, CTGF overexpression caused a decrease of the specific isometric contractile force. Strikingly, when CTGF overexpression stopped, the entire phenotype proved to be reversible, in parallel with normalization of CTGF levels.
Altogether these results provide strong evidence for a critical role of CTGF in skeletal muscle fibrosis in vivo. CTGF not only acts downstream of muscle injury, but contributes directly to deterioration of skeletal muscle phenotype and function.
These observations underscore the importance of CTGF in the patho-physiology of muscular dystrophies and suggest that targeting CTGF might have significant potential in development of novel therapies for Duchenne muscular dystrophy and related diseases.
( The formation and maturation of blood vessels by angiogenesis (sprouting from preexisting blood vessels) or vasculogenesis (de novo formation of vessels from angioblasts or stem cells) is orchestrated by a constellation of physical and chemical factors whose spacio-temporal patterns of expression and concentration are tightly regulated. Functional redundancy among some angiogenic and vasculogenic factors is generally assumed but dysregulation of some key factors may result in either vascular regression or the formation of an abnormal vasculature, a hallmark feature of ischemic retinopathies including retinopathy of prematurity. ROP is characterized by a vaso-obliteration phase caused by a disrupted oxygen environment in the retina, and a subsequent ischemia-induced neovessel formation phase characterized by the growth of abnormal leaky blood vessels which rupture and cause blindness. At present, the contribution of local and systemic regulation of normal and pathologic vessel growth is unclear. The CCN1 protein also known as cysteine-rich protein 61 is a dynamically expressed and locally produced protein required for proper angiogenesis and vasculogenesis during development. Interestingly, the expression of CCN1 becomes abnormally reduced during the hyperoxic and ischemic phases of ROP modeled in the mouse eye with oxygen-induced retinopathy (OIR). Lentivirus-mediated reexpression of CCN1 enhanced physiological adaptation of the retinal vasculature to hyperoxia and reduced pathological angiogenesis following ischemia. Remarkably, injection into the vitreous of OIR mice of hematopoietic stem cells (HSCs) engineered to express CCN1 harnessed ischemiainduced neovessel outgrowth without adversely affecting the physiological adaptation of retinal vessels to hyperoxia. In vitro exposure of HSCs to recombinant CCN1 induced integrin-dependent cell adhesion, migration, expression of specific endothelial cell markers as well as many components of the Wnt signaling pathway including Wnt ligands, their receptors, inhibitors and downstream targets. CCN1-induced Wnt genes mediates, at least partly, adhesion, migration and endothelial differentiation of cultured HSCs, and inhibition of Wnt signaling interfered with the normalization of the retinal vasculature induced by CCN1-primed HSCs in OIR mice. These newly identified functions of CCN1 suggest its major importance in blood vessel normalization and integrity during blood vessel formation and repair. Smoking has been known as a critical risk factor that promotes periodontal tissue damage accompanied by fibrotic changes. In this context, it should be noted that CCN2 was shown to be a key molecule mediating gingival fibrosis induced by systemic administration of certain drugs. Therefore, in order to examine the involvement of CCN2 in the pathogenesis of smoking-induced periodontal fibrosis, we performed a series of analyses in vitro, which uncovered a critical role of CCN2 therein. Human gingival fibroblasts (HGFs) and periodontal ligament cells (PDLs) were obtained upon the extraction of normal teeth and were maintained in vitro. These cells were treated with a variety of concentrations of nicotine for 12-48 h to evaluate its pathobiological effects. Reverse transcription (RT)-mediated PCR analysis of the RNAs extracted from these cells revealed no significant induction of CCN2 mRNA by nicotine at the concentrations evaluated; however, enzyme-linked immunosorbent analysis (ELISA) showed significant enhancement of CCN2 protein production from both types of the cells by 1 μg/ml of nicotine treatment. These results suggest a posttranscriptional regulation of CCN2 gene expression by nicotine, although its precise mechanism remains to be investigated. Moreover, gene expression and protein production of type I collagen, which is the major component of fibrotic extracellular matrix (ECM), were significantly promoted by the same concentration of nicotine. As expected, this promotion of type I collagen deposition was neutralized by a specific antibody against CCN2, indicating the contribution of CCN2 to the increased collagen production by nicotine stimulation.
ROLE OF CCN2 IN THE REMODELING OF PERIODONTAL TISSUE UPON NICOTINE EXPOSURE

Satoshi
In addition to the effect on CCN2 production, our subsequent investigation uncovered other critical functional aspects of the nicotine to promote periodontal tissue remodeling. Upon the treatment of HGF with 1 μg/ml of nicotine, cell proliferation and migration were remarkably attenuated, which might interfere with normal healing process of periodontal tissues upon injury. Of note, ELISA revealed the enhanced production of tissue inhibitor of matrix metalloproteinase 1 (TIMP-1) from both HGFs and PDLs after the nicotine treatment. Since TIMP-1 is an inhibitor of matrix metalloproteinases (MMPs), nicotine is thought to indirectly promote ECM accumulation by affecting the balance of matrix remodeling. Possible role of CCN2 in the pathological remodeling of periodontal tissue by nicotine will be comprehensively discussed, together with these other related factors.
CCN2 IN CARTILAGE
Karen Lyons
University of California, Los Angeles, Orthopaedic Hospital Research Center, 410C 615 Charles E Young Dr. South, Los Angeles, CA 90095 USA CCN2/connective tissue growth factor is highly expressed in hypertrophic chondrocytes and is required for chondrogenesis. However, the transcriptional mechanisms controlling its expression in cartilage are largely unknown. The activity of the Ccn2 promoter was therefore investigated in osteochondro-progenitor cells and hypertrophic chondrocytes to ascertain these mechanisms. Sox9 and T-cell factor (TCF) x lymphoid enhancer factor (LEF) factors contain HMG domains and bind to related consensus sites. TCF x LEF factors are normally repressive but when bound to DNA in a complex with beta-catenin become activators of gene expression. In silico analysis of the Ccn2 proximal promoter identified multiple consensus TCF x LEF elements, one of which was also a consensus binding site for Sox9. Using luciferase reporter constructs, the TCF x LEF x Sox9 site was found to be involved in stage-specific expression of Ccn2. Luciferase, electrophoretic mobility shift assay (EMSA), and ChIP analysis revealed that Sox9 represses Ccn2 expression by binding to the consensus TCF x LEF x Sox9 site. On the other hand, the same assays showed that in hypertrophic chondrocytes, TCF x LEF x beta-catenin complexes occupy the consensus TCF x LEF x Sox9 site and activate Ccn2 expression. Furthermore, transgenic mice in which lacZ expression is driven under the control of the proximal Ccn2 promoter revealed that the proximal Ccn2 promoter responded to Wnt signaling in cartilage. Hence, we propose that differential occupancy of the TCF x LEF x Sox9 site by Sox9 versus beta-catenin restricts high levels of Ccn2 expression to hypertrophic chondrocytes. In the course of these studies, we discovered high levels of CCN2 expression in the nucleus pulposus, a tissue derived from the notochord that plays an essential role in the ability of the intervertebral discs to withstand compressive forces. Loss of CCN2 in this tissue leads to major defects in the ability of the nucleus pulposus to produce ECM components required for its proper function. Moreover, the annulus fibrosis,a tissue that surrounds the nucleus pulposus and is required for maintenance of the intervertebral disc, is also severely impacted. Thus, CCN2 appears to play an essential role in multiple skeletal tissues, and may be a key factor in the progression of intervertebral disc degeneration. While type 2 diabetes is an independent risk factor for progression of (NASH) in man, animal models to examine this have not been developed. We recently published that short term 5 weeks duration of type 2 diabetes exacerbates liver fibrosis in a 15 weeks mouse model of diet-induced obesity causing NASH. CCN-2 is implicated in causing series of diabetes related complications including NASH, and we now report a more severe pathology occurs where model duration is extended.
CCN-2 IS IMPLICATED AS A CAUSAL FACTOR IN A MODEL WHICH SHOWS DIABETES IS A PROGRESSION FACTOR AND INDUCES CIRRHOSIS IN NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Lisa
Wild type C57BL/6 male mice (n=31) were fed a high fat diet (HFD: 45%kCal fat) or standard laboratory chow (CHOW: 12%kCal fat) ad libitum, for 15 weeks, when after randomisation some animals were made diabetic (HFD+ DM or CHOW+DM) with mini-dose STZ. After a further 22 weeks of diabetes animals were terminated. Liver histology was assessed and scored using Brunt and Kleiner criteria and pro-fibrotic markers analysed by qRT-PCR. BGL, serum albumin and bilirubin were determined.
Data are mean±SEM, *P<0.05 vs CHOW.
HFD+DM mice histologically had significantly increased intra-acinar inflammation and more severe stages of liver fibrosis, and 6/12 of the HFD+DM group showed changes of cirrhosis. By qRT-PCR, hepatic pro-fibrotic markers including CCN-2 and TIMP-1, were increased in HFD+DM (by 6 and 38 fold respectively, each p<0.05 vs CHOW). The HFD+DM group also had liver dysfunction, with lower circulating albumin (CHOW:43.8±3.4 vs HFD+ DM:29.2 ± 2.5 g/L) and higher total bilirubin levels (CHOW:0.60±0.02 vs HFD+DM:1.13±0.28 g/L), each P< 0.05. Early insulin treatment prevented fibrosis changes (not shown). This novel long-term model indicates that diabetes contributes to progression from NASH to more end-stage liver disease. Subsequent studies will further define molecular mechanisms of this process and if CCN-2 is causal. Supported by NHMRC of Australia Project Grant #632822.
YOUNG INVESTIGATOR SESSION ABSTRACTS IMMUNE RESPONSES IN ALCOHOL-INDUCED PANCREATIC INJURY ARE ASSOCIATED WITH CCN2 EXPRESSION AND ACTION IN ACINAR CELLS
Alyssa Charrier and David Brigstock
The Ohio State University and Nationwide Children's Hospital Research Institute, Columbus OH Introduction: Alcoholic chronic pancreatitis (ACP) is characterized by pancreatic necrosis, inflammation, and scarring, the latter of which is due to excessive collagen deposition by activated pancreatic stellate cells (PSC). We have have previously shown that in a novel model of ACP in mice (a species that is usually resistant to the toxic effects of alcohol), PSC are principally responsible for the production of connective tissue growth factor (CCN2) which is correlated spatially and temporally with sites of collagen production (Charrier & Brigstock; Lab Invest, 2010) . This is consistent with our earlier in vitro data showing that PSC produce collagen in response to ethanol via the production of CCN2 (Lawrencia et al; Growth Factors, 2009) . During the course of the in vivo studies, we observed that, prior to the fibrotic phase (>Day 20), the combination of ethanol and cerulein caused a transient increase in CCN2 production in acinar cells, even though these cells are not collagenic. Thus we adopted in vivo and in vitro approaches to investigate this finding further Methods: C57/Bl 6 mice received ethanol injections for 6-16 days against a background of cerulein-induced acute pancreatitis. Pancreata from mice that were treated with cerulein plus 33% ethanol were examined at Days 6, 9, 13, and 16 for the presence of CCN2 and its relationship to inflammatory responses. Additionally, the rat acinar cell line, AR42J, was grown in culture and treated with either ethanol or CCN2 siRNA prior to determination of interluekin-1B (IL-1β) expression by real-time PCR. Results: In the in vivo model, there was strong immunofluorescent signal for CCN2 in acinar cells by Day 16 of treatment with ethanol + cerulein and this was not colocalized to α-SMA-postive smooth muscle cells of the vasulature. This pattern of CCN2 staining was not apparent in pancreata of mice receiving water + 33% ethanol. F4/80 immunofluorescence showed some macrophage infiltration of pancreatic tissue at days 6 and 9, but this was substantially increased on Day 16 and thus correlated with CCN2 production by acinar cells. Immunofluorescence staining further demonstrated that the increase in acinar CCN2 by ethanol + cerulein was spatially and temporally correlated with than of IL-1β. In vitro studies showed that after treatment of rat AR42J cells with 6.25-100 mM ethanol for 24 or 48 h, the pattern of CCN2 mRNA induction was correlated with that of IL-1β expression. A functional link between CCN2 and IL-1β was shown by the reduction of Ll-1β expression in rat AR42J cells after knockdown of CCN2 mRNA using CCN2 siRNA.
CHOW (5) Purpose: Cysteine-rich angiogenic inducer 61 (Cyr61, CCN1) is an extracellular matrix protein involved in the transduction of growth factor and hormone signaling. Previously we demonstrated that Cyr61 was highly expressed in prostate cancer (PCa) but that the expression levels were associated with a lower risk of PCa recurrence. In the present study, we demonstrate that serum Cyr61 is a potential biomarker that correlates with PCa aggressiveness. Furthermore, we also explore the potential mechanism underlying the changes in Cyr61 expression during PCa progression. Materials and Methods: Cyr61 concentrations in the medium from PCa cell lines and in serum samples obtained from PCa patients were measured by sandwich ELISA. Serum Cyr61 levels were correlated with disease characteristics and the association between Cyr61 expression changes by several types of stimulation or stress and cAMP/cAMP-dependent protein kinase (PKA) pathway were examined. Results: There was a positive correlation between Cyr61 levels in cell supernatants and mRNA expression in these cell lines. Serum Cyr61 levels were significantly higher in non-organ-confined PCa patients (116.3±140.2 ng/ml) than in organ-confined PCa patients (79.7±56.1 ng/ml) (p= 0.031). Cyr61 expression was up-regulated in response to both lysophosphatidic acid and androgen treatments which promoted PCa cell invasion. Serum starvation and phosphoinositide-3-kinase inhibition also resulted in Cyr61 up-regulation however they suppressed cell proliferation. Cyr61 up-regulation was correlated with an increase in cAMP and suppressed by PKA inhibition. Conclusions: These findings suggest that Cyr61 expression in PCa is regulated by the cAMP/PKA pathway and that circulating Cyr61 levels are a potential serum-based biomarker for characterizing PCa. CCN2 (also known as connective tissue growth factor: CTGF) interacts with several growth factors involved in endochondral ossification via its characteristic 4 modules and modifies the effect of such growth factors. Presently we investigated whether or not CCN2 interacts with fibroblast growth factor 2 (FGF2). Solid-phase binding assay, immunoprecipitation-Western blot analysis, and surface plasmon resonance (SPR) spectroscopy revealed that the C-terminal module of CCN2 (CT) directly bound to FGF2 with a dissociation constant (Kd) of 5.5 nM. Next, we examined the combinational effects of CCN2 and FGF2 on the proliferation of and matrix metalloproteinase (MMP) 9 and 13 productions by cultured chondrocytes. FGF2 promoted not only the proliferation but also the production of MMP9 and 13, however, combined of FGF2 with CT module nullified the enhancement of both MMPs productions and proliferation. To clarify the mechanism, we investigated the binding of CCN2 or its CT module to FGF receptor 1 (FGFR1). As a result, we found that CCN2 bound to FGFR1 with a Kd of 362 nM, whereas the CT module did not. In addition, when we tested FGF signaling in HCS-2/8 cells stimulated by the combination of FGF2 with CT module, the level of ERK1/2, p38 MAPK, and JNK phosphorylation was decreased compared with that found with FGF2 alone. These findings suggest that CCN2 may regulate the proliferation and matrix degradation of chondrocytes by forming a complex with FGF2 as a novel modulator of FGF2 functions.
EFFECT OF CCN2 ON FGF2-INDUCED PROLIFERATION OF AND MMP9 AND 13 PRODUCTIONS BY CHONDROCYTES
PERIOSTIN MODULATES MYOFIBROBLAST DIFFERENTIATION DURING FULL THICKNESS CUTANEOUS WOUND REPAIR
Christopher G. The various influences of matricellular proteins on wound repair provide a multitude of avenues for exploration of potential targets for fibrosis and chronic wounds. Despite mounting evidence for the importance of matricellular proteins in wound contraction and re-epithelialization, no clinical trials are currently employing these proteins for the resolution of chronic wounds. A more thorough examination of the role of matricellular proteins in dermal wound repair is needed in order to determine their suitability as therapeutics. The matricellular protein periostin is expressed in the skin. Although periostin has been hypothesized to contribute to dermal homeostasis and repair, this hypothesis has not been directly tested.To assess the contribution of periostin to dermal healing, 6 mm full thickness excisional wounds were created in the skin of periostin knockout and wild-type/sex-matched control mice. In wild-type mice, periostin was potently induced 5-7 days post-wounding. In the absence of periostin, day 7 wounds showed reduced numbers of myofibroblasts, as visualized by α-smooth muscle actin (α-SMA) expression within the granulation tissue. Isolated wild-type and knockout dermal fibroblasts did not differ in in vitro assays of adhesion or migration; however, in 3D culture, periostin knockout fibroblasts showed significantly reduced ability to contract a collagen matrix, and adopted a dendritic phenotype. Recombinant periostin, in a fashion which was sensitive to a neutralizing anti-β1-integrin and to the FAK/src inhibitor PP2, restored the defects in cell morphology and matrix contraction displayed by periostin-deficient fibroblasts. We propose that periostin promotes wound contraction by facilitating myofibroblast differentiation and contraction.
COMPARATIVE ANALYSIS OF CCN2 AND PAI-1 (SERPINE1) INDUCTION IN RESPONSE TO PROFIBROTIC GROWTH FACTORS (E.G., TGF-β1, EGF) AND MICROTUBULE ALTERATIONS
Rohan Samarakoon and Paul J. Higgins Albany Medical Center 43 New Scotland Avenue, Albany, NY 12208
Profibrotic matricellular proteins CTGF (CCN2) and PAI-1 are highly-induced during the progression of renal fibrosis and cardiovascular disorders. Since PAI-1 and CTGF are prominent downstream targets of TGF-β1 major profibrogenic cytokine growth factor, a comparative analysis of signaling cascades (e.g., SMAD and non-SMAD) involved in PAI-1 and CTGF induction in vascular smooth muscle cultures and fibroblasts was undertaken. TGF-β1 stimulation of CTGF and PAI-1 expression required SMAD3 activation as RNA interference and pharmacological inhibition of SMAD3 virtually eliminated these responses. TGF-β1 mediated activation of Src-FAK-EGFR signaling cascades were critical for activation of both CTGF and PAI-1 genes as induction was largely absent in EGFR, Src and FAK-deficient mouse embryo fibroblasts. Moreover, pharmacological blockade of EGFR signaling by AG1478 as well as DN-EGFR expression effectively suppressed PAI-1 and CTGF induction by TGF-β1 in VSMCs. Surprisingly, EGF-stimulated PAI-1 and CCN2 expression also required SMAD3 signaling further highlighting cross talk between receptor tyrosine kinase (e.g, EGFR) and serine threonine kinase (e.g., TGF-β1 receptor) cascades in gene induction. Interestingly, cell shape alterations by disruption of microtubule cytoskeleton also activated EGFR and Rho-A and SMAD signaling and EGFR and Rho-A activation is critical for both CCN2 and PAI-1 expression while SMAD activation is dispensable for CCN2 induction but not PAI-1. These findings highlight a complex network of both common and unique signaling control elements that can be of potential translational value in the simultaneous targeting of CTGF and PAI-1, major causative factors of fibrotic and vascular pathologies (Supported by NIH Grant GM057242). Connective tissue growth factor (CTGF, CCN2) has emerged as an important growth factor for skeletogenesis. Its importance in skeletogenesis is seen in global CTGF knockout (KO) mice, which demonstrate defects in growth plate chondrogenesis and skeletal defects including kinked ribs, tibiae, radii and ulnae, and craniofacial abnormalities. Ultimately, global ablation of CTGF results in neonatal lethality from respiratory failure. This study addressed the effects of global CTGF ablation on skeletogenesis using quantitative techniques, such as micro-CT. Furthermore, to discern any differences in the separate processes of ossification affected by CTGF ablation, specific bone sites and cells were studied. To address our goals, we used: (a) micro-CT analysis of long bones and skulls to assess phenotypic differences, (b) histomorphometric analyses to assess parameters of endochondral bone formation, and (c) ex vivo studies to assess bone cell function. Analysis of distal femoral and proximal tibial metaphyses demonstrated a decrease in trabecular bone volume in CTGF KO mice compared to WT littermates. In CTGF-null tibial diaphyses (the region of the structural kink), total tissue volume, bone volume and bone perimeter were markedly increased, compared to WT tibiae. CTGF-null skulls demonstrated decreases in cranial bone mineralization (being absent in some sites), increases in suture and fontanel size, and a clear failure of midline convergence of the maxillary and palatine processes to form the palate. This was also accompanied by asymmetry of the vomer, a consistent feature found in CTGF-null skulls. Histomorphometric analyses of WT and CTGF-null tibiae showed differences in various parameters of endochondral bone formation, including decreased osteoblast cell numbers immediately below the growth plate, decreased bone matrix formation, and increased hypertrophic zone thickness. We also demonstrated a unique dichotomy of bone formation in the kinked tibiae, where ossification at the kink appears to form by a mechanism distinct from the region under the growth plate. Lastly, ex vivo studies from isolated primary osteoblasts revealed a decreased ability of CTGF-null osteoblasts to adhere to bone matricellular proteins, such as fibronectin, and decreased ability to proliferate. This study is crucial in elucidating the role of CTGF in bone development, because it has for the first time addressed the effects of CTGF ablation on bone development using quantitative techniques, such as micro-CT and histomorphometric analyses. Using such techniques, we have demonstrated quantitative defects in both endochondral and intramembranous ossification processes by studying long bone trabeculae and skull flat bones, respectively. Our ex vivo studies using CTGF-null primary osteoblasts showed defects involving differentiation and function. These studies provide new information on the bone phenotype observed in CTGF KO mice, and thereby help define the importance of CTGF for normal bone development. Background: Idiopathic pulmonary fibrosis (IPF) is a devastating disease, with progressive scarring of the lungs, poorly responsive to current treatment options. Lung cancer is frequently associated with IPF. Connective tissue growth factor (CTGF/CCN2) is a cysteine-rich secreted matricellular protein involved in wound healing and tissue repair. Enhanced and prolonged expression of CCN2 has been associated with tissue fibrosis. Several lines of evidence implicate the angiotensin system in the pathogenesis of lung fibrosis. This study was undertaken to investigate whether CCN2 effects are mediated through activation of angiotensin system signaling transduction pathways. Methods: Lung fibroblasts isolated from IPF and from control lungs (6 each) were used between passage 2-5. IPF and control fibroblast treated with or without Angiotensin II (Ang II; 100 nM) expression of CCN2, type I collagen (Col I), PTEN, angiotensin receptors, and alpha-smooth muscle actin (alpha-SMA) were examined using immunofluorescence staining and Western blot. The ability of Ang II to enhance fibroblast contraction in a collagen gel contraction and migratory ability were also examined. Ang II and CCN2 levels in fibroblast supernatants were examed by Elisa. Signalling pathways were evaluated using selective pharmacological inhibitors, including PI3-kinase/AKT inhibitors wortmanin (0.1 μM) and LY294002 (20 μM).
CCN2 IS REQUIRED FOR NORMAL INTRAMEMBRANOUS AND ENDOCHONDRAL OSSIFICATION
POSTER SESSION ABSTRACTS CCN2 IS A KEY MEDIATOR OF IDIOPATHIC PULMONARY FIBROSIS (IPF)
Results: IPF fibroblast and control cells treated with AngII were expressed significantly higher CCN2 (p<0.05) and other matrix proteins and lower PTEN (p<0.05) than in control cells. IPF fibroblasts secrete increased CCN2 and Ang II levels compared to control fibroblasts. AngII significantly enhanced the ability of control lung fibroblasts to contract a collagen gel matrix by inducing the expression of CCN2, alpha-SMA and by increasing lung fibroblast migratory capability; these features were significantly inhibited by AT1 specific antagonist Losartan (p<0.05). IPF fibroblasts displayed higher levels of CCN2, alpha-SMA and increased collagen gel contractility compared to controls; these characteristics were significantly reversed by treatment with Losartan, as well as by PI3kinase/AKT inhibitors, compared to controls, Conclusions: CCN2 is key mediator in IPF. Treatment of IPF lung fibroblasts with either Losartan or PI3 kinase/AKT inhibitors reduces IPF fibroblasts contractility and matrix to levels seen in control lung fibroblasts, with potential clinical implications for the treatment of fibrotic lung diseases. Objective: CCN family proteins play important roles in differentiation and regeneration of cartilaginous tissues. CCN2/CTGF is known to promote the regeneration of articular cartilage by promoting cell growth and extracellular matrix production. This protein comprises 4 highly interactive independent modules, each of which was suggested to have its own biological activity. Based on these findings, it is suspected that different combinations of these modules may exert unexpected biological effects through mutual molecular interaction. This study aims to assess the effects (resulting from these different combinations) on chondrocytic cells especially in relation to full length CCN2, as well as the direct interaction between these modules. Methods: Four independent modular proteins of human CCN2 were produced and purified through recombinant protein production system with Brevibacillus choshinensis. Physical interaction of 2 modules was kinetically examined by a surface plasmon resonance (SPR) methodology. Effect of a single module, or a combination of independent modules was evaluated with human chondrocytic HCS-2/ 8 cells. Chondrocytic phenotype was estimated by the gene expression of aggrecan, type II collagen, and matrix metalloproteinase 13 via real time RT-PCR analysis. Proteoglycan synthesis and proliferation of chondrocytes were evaluated by [ Introduction: Unlike skin, oral gingival do not scar in response to tissue injury. Fibroblasts, the cell type responsible for connective tissue repair and scarring, are exposed to mechanical tension during normal and pathological conditions including wound healing and fibrogenesis. Understanding how human gingival fibroblasts respond to mechanical tension is likely to yield valuable insights not only into gingival function but also into the molecular basis of scarless repair. Objective: To study how human gingival fibroblasts respond to mechanical stress and understanding the molecular mechanism underlying the ability of strain to modulate gene expression in gingival fibroblasts. Methods: Gingival fibroblasts were subjected to cyclical strain (up to 72 h) using the Flexercell system and the response of mechanical strain on gene expression in gingival fibroblasts was investigated by monitoring the alterations in (a) CCN2 expression using real-time polymerase chain reaction (PCR) and Western blot analyses; (b) total/active TGFbeta expression and Endothelin1 expression using real-time PCR and ELISA; (C) genome-wide mRNA expression using micro-array profiling. Results: Strain caused the rapid activation of latent TGFβ, in a fashion that was reduced by blebbistatin and FAK/src inhibition, and the induction of endothelin (ET-1) mRNA and protein expression. Strain did not cause induction of α-smooth muscle actin or collagen type I mRNAs (proteins promoting scarring); but induced a cohort of proproliferative mRNAs and cell proliferation. Compared to dermal fibroblasts, gingival fibroblasts showed reduced ability to respond to TGFβ by inducing fibrogenic mRNAs; addition of ET-1 rescued this phenotype. Pharmacological inhibition of the TGFβ type I (ALK5) receptor, the endothelin A/B receptors and FAK/src significantly reduced the induction of CCN2 and pro-proliferative mRNAs and cell proliferation. Conclusion: Controlling TGFβ, ET-1 and FAK/src activity may be useful in controlling responses to mechanical strain in the gingiva and may be of value in controlling fibroproliferative conditions such as gingival hyperplasia; controlling ET-1 may be of benefit in controlling scarring in response to injury in the skin. While the underlying causes are diverse, it is likely that many of the harmful aspects of fibrosis are mediated by transforming growth factor-β1 (TGF-β1), a pleiotropic cytokine. Previously, we used an adenovirus to deliver and chronically overexpress TGF-β1 at high levels in the knee joints of immunocompromised nude rats, which led to very severe arthrofibrosis (Watson et al, 2010) . The amount of TGF-β1 produced by the virus delivered in these experiments represented an extreme response to stimulation with this transgene. While relevant to various diseases of the joint, including synovial chondromatosis, chondrometaplasia, osteosarcoma and chondrosarcoma, it showed no signs of resolving. Therefore, in an effort to understand the biological processes that contribute to the development and resolution of arthrofibrosis and frozen shoulder, we wanted to establish an animal model that more closely reflected the level of disease in humans. As cells expressing nonhomologous transgenic proteins are immunologically cleared from the joints of immunocompetent Wistar rats within 21 days (Gouze et al, 2007) , we used this system to examine the effects of short term production of TGF-β1 intra-articularly, with the goal of inducing a fibrotic event that will more closely mirror the stages of IAC. To enable a comprehensive description of the biology of IAC at the molecular level, we performed human genome array analyses to determine the differences in global transcription patterns between normal capsular tissues and those from patients with IAC.
CHARACTERIZATION OF THE EFFECT OF CCN2 MODULES INDEPENDENTLY AND IN DIFFERENT COMBINATIONS ON CHONDROCYTIC CELLS
CCN2 EXPRESSION AND LOCALIZATION
By observing animals over the course of 120 days and delivering a low dose of Ad.TGF-β1, we hypothesized that the animals would undergo a remodeling process similar to stage 4 IAC. To follow the changes in gene expression over the course of disease in the capsular tissues, we used realtime PCR technology and histologic analysis. We found that TGF-β1 gene transfer very rapidly induced a fibrotic condition that completely encased and immobilized the injected joint, induced a chondrogenic response, and over the course of the 120 day experiment, gradually resolved into a less aggressive, less fibrotic, and overall less cellular tissue. Using PCR arrays, we were able to establish the signaling patterns occurring throughout this process. These patterns were comparable to expression data obtained from human patients with IAC, with similar extracellular matrix, MMP, adhesion and collagen proteins upregulated in both human and rat fibrosis. Histologic examination, as well as focused expression arrays of the joint tissues over time, suggested the developing fibrotic tissue adopted a phenotype similar to that of IAC and gradually remodeled with time. Glia scar consisting mostly of reactive astrocytes with upregulated glial fibrillary acidic protein (GFAP) is often present in lesion sites of brain injuries such as a stab wound or ischemia. It is similar but distinct from the inflammatory response observed in fibrosis that involves hardening of connective tissue. The formation of glia scar is believed to prevent harmful substances released by the damaged cells from affecting the surrounding healthy brain tissue. However, the same scar tissue also hinders regeneration of neurons necessary for full recovery of brain function. Until now, the intermediate filament GFAP is the most reliable marker for a glia scar. This study therefore seeks to explore alternative proteins that can be accessible for targeted therapeutic intervention. The gap junction protein connexin43 (Cx43) is widely expressed in adult astrocytes and its expression is upregulated in the peri-lesional region. As a channel protein, Cx43 is predicted to play a key role in intercellular communication critical for proper wound repair and neuroprotection. By correlating the temporal and spatial expression of Cx43 by immunohistochemistry to the activation of astrocytes and microglia (the immune cells in the brain) in response to an acute needle stab wound, we showed that the kinetics of Cx43 expression primarily followed the temporal and spatial distribution of reactive astrocytes. We also examined the presence of nestin-expressing progenitors that are known to be recruited to lesion sites. Our results revealed that the initial response of the host brain involves proliferation of reactive microglia that were devoid of Cx43 within the injury site from 3 h to 3 days post injury (dpi), with a concurrent migration of Cx43-and GFAP-positive reactive astrocytes towards the lesion. Increased Cx43 and GFAP protein expression were detected within the lesion from 6 dpi onwards. Although there was also a transient increase of nestin-positive cells in the needle wound, only Cx43 and GFAP proteins were detected at 2 weeks post injury. Taken together, our findings indicate Cx43 is a good alternative biomarker for brain injury.
GAP JUNCTION PROTEIN
